Patient-Portal vs Text-based Hypertension Monitoring Among Black Medicaid/Medicare Patients

Hypertension Clinical Trial

Official title:

Patient-Portal vs Text-based Hypertension Monitoring Among Black Medicaid/Medicare Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05186831
• Other study ID #: University of Pennsylvania
• Status: Completed
• Phase: N/A
• Start date: October 19, 2020
• Est. completion date: January 14, 2021

Study information

• Verified date: December 2021
• Source: University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The coronavirus disease 2019 (COVID-19) pandemic has uprooted conventional health care delivery for routine ambulatory care, requiring health systems to rapidly adopt telemedicine capabilities. The digital divide, has been well documented with lower rates of technology and broadband adoption among racial/ethnic minorities. Additionally, Black patients suffer a disproportionate burden of hypertension and cardiovascular disease. This study will implement a text-based home hypertension monitoring program among Black Medicaid patients with hypertension and cardiovascular disease (CVD) and compare its uptake to the currently available blood pressure monitoring program using the patient portal that is integrated into the electronic health record (EHR).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: January 14, 2021
• Est. primary completion date: December 29, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Self-identified Black race

• Medicaid or Medicare insurance

• Hypertension

• Cardiovascular disease or presence of at least 1 cardiovascular risk factor

• Seen for in-person consultation at the Heart and Vascular clinic at the Hospital of the University of Pennsylvania

Exclusion Criteria:

• Does not speak English

• Already owns a BP cuff

• Does not have internet access or a phone 15 with texting capabilities

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Hypertension

Intervention

Behavioral:
• Texting
Patients will be asked to text their BP. They will receive an automated response to their texts.
• Online patient portal
Patients will be asked to upload their BP to the online patient portal. They will receive information on how to sign up and use the patient portal. Patients can upload their BP readings daily or at the end of the study period.

Locations

Country	Name	City	State
United States	University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of BP measurements reported	Number of BP results reported over the study period	14 days
Primary	Proportion of patients submitting 1 or more BP measurement	Proportion of patients per study arm reporting at least one BP measurement	14 days
Secondary	Patient satisfaction	Patients will be asked to complete a survey about ease of use and likelihood of recommending the intervention	Within 2 weeks of end of study period